Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.10
-0.10 (-0.31%)
Aug 19, 2026, 1:30 PM CST

Taiyen Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,1903,3083,2383,4093,6144,096
Revenue Growth
-3.27%2.15%-5.01%-5.67%-11.77%30.84%
Gross Profit
1,2571,3411,3211,2571,2771,373
Operating Income
425.06474.19354.54321.44445.05529.18
Net Income
389.53399.87371.52300.39426.7393.23
Earnings Per Share
1.941.991.851.502.131.96
EPS Growth
10.85%7.57%23.33%-29.58%8.67%7.69%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Salt Products and Packaged Water
2,6072,6702,6082,6362,4822,370
Other Department
107.11104.6884.3180.7366.1561.88
Biotechnology Cleaning and Maintenance Department
427.79470.07470.57474.59515.91432.37
Engineering and Labor Department
75.6188.5994.47319.25570.361,254
Adjustments and Eliminations
-28.06-25.46-18.75-102.24-20.64-23.32
Total
3,1903,3083,2383,4093,6144,096

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,9661,7461,9381,8401,8822,080
Total Debt
112.22125.52205.2220.17135.44391.98
Net Cash (Debt)
1,8531,6201,7331,6191,7471,688
Net Cash Growth
2.29%-6.49%7.00%-7.29%3.46%0.42%
Net Cash Per Share
9.248.078.648.088.718.42

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
553.6432.05660.12454.54580.69600.08
Capital Expenditures
-303.64-300.16-307.61-341.65-246.11-388.79
Free Cash Flow
249.96131.89352.51112.89334.58211.29
Free Cash Flow Growth
-33.50%-62.59%212.26%-66.26%58.35%183.28%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.40%40.54%40.79%36.89%35.33%33.53%
Operating Margin
13.33%14.34%10.95%9.43%12.32%12.92%
Pretax Margin
15.06%14.93%13.37%9.65%14.68%12.45%
Profit Margin
12.21%12.09%11.47%8.81%11.81%9.60%
FCF Margin
7.84%3.99%10.89%3.31%9.26%5.16%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.4001.4001.3001.2001.5001.500
Dividend Per Share Growth
7.69%7.69%8.33%-20.00%0%11.11%
Dividend Yield
4.35%4.42%4.17%3.78%5.21%5.32%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.5515.8617.4722.7715.2116.89
Forward PE
-15.5215.5215.5215.5215.52
P/FCF Ratio
25.6848.0718.4160.5919.4031.43
PS Ratio
2.011.922.002.011.801.62